Structural Heart Market to Reach US$ 13,850.2 Million at CAGR of 10.5% by 2025 | The Insight Partners

report image

Structural Heart Market to 2025 - Global Analysis and Forecasts By Product (Occluders, Annuloplasty Rings, Heart Valve Balloons, and Others) By Procedure (Surgical Aortic Valve Replacement, Transcatheter Aortic Valve Replacement, Mitral Repair and Left Atrial Appendage Closure); By End User (Hospitals, Ambulatory Surgical Centers and Cardiac Centers) and Geography

Publication Month: Oct 2018 | Report Code: TIPHE100001164 | No. of Pages: 146 | Category: Medical Device | Status: Published

The global structural Heart market accounted to US$ 6,406.3 Mn in 2017 and is expected to grow at a CAGR of 10.5% during the forecast period 2018 - 2025, to account to US$ 13,850.2 Mn by 2025.

North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period. North American market is driven by the factors such as, rising prevalence of heart diseases, growing number of regulatory approvals and product launches in the region.

 Lucrative Regional Markets

Get more information on this report :

Market Insights

Innovative Structural Heart Services

The rise in technological advancement has led to various innovations for the products and treatment services that enables the surgeon, physicians and other healthcare providers to provide best health to their patients. The innovations are not only limited to the healthcare facilities nevertheless they are extended to the programs that are being designed for the patients to get benefit out of the treatment facilities. Food and Drug Administration (FDA) has approved various therapies that are limited to the selected groups of the patients. There some personal healthcare provider who analyze the heart condition and available treatment of choices. For instance, Premier Health is among those providers who provides innovative structural heart services which include alcohol septal ablation which treats hypertrophic cardiomyopathy with the use of catheter-based technology, balloon valvuloplasty which uses a transcatheter approach for widening up a stiff and narrow heart valves, atrial septal defect transcatheter repair which closes an opening between the heart’s left and right atrium without surgery and such more services are being provided by the service providers.

Rise in the Number of Cardiovascular Procedure and Corresponding Training Programs

The cardiac arrest or the other heart related diseases are wide spreading incidence and are impacting severely on the public health and wellbeing. The cardiovascular disease are the second leading cause of death across the world. For instance, according to World Health Organization (WHO) approximately 17.7 million people died in 2015 due to the cardiovascular diseases, the number contributes to the 31% of the global deaths. The among these deaths it was estimated that near about 7.4 million deaths were due to coronary heart diseases and near about 6.7 million deaths were due to the heart stroke. Among the 17 million deaths the premature deaths were contributed due to non-communicable diseases in 2015, this number relates approximately to 82% were in low and middle-income countries, and approximately 37% were due to CVDs. Therefore, various strategies and initiations are being taken to control the cardiovascular diseases.

Product Insights

The global structural heart market by product was led by occluders segment. In 2017, the occluders segment held a largest market share of 42.0% of the structural heart market, by product. The segment is also expected to dominate the market during the year 2025, due to benefits such as, 50% of reduction in the meshwork material on the left atrial side and eliminates the left atrial disc microsrew, minimizes the risk of thrombus formation and damage to the distal wall of the left atrium during the implantation procedure

Procedure Insights

The structural heart market by procedure was segmented into surgical aortic valve replacement, transcatheter aortic valve replacement, mitral repair and left atrial appendage closure. The surgical aortic valve replacement segment held the largest share of the market, by procedure. The segment is also likely to dominate during the forecast period, as it helps in restoring the normal blood flow, prolong life and help to preserve the function of heart muscles.

End User Insights

The structural heart market by end user was segmented into hospital, ambulatory surgical centers and cardiac centers. The hospitals segment held the largest share of the market, by end user. The segment held a market share of around 49.9% during the year 2017 and is anticipated to dominate by 2025, among the end users.

 Structural Heart Market, by End User

Get more information on this report :

Strategic Insights

Report Coverage - Structural Heart Market
Report CoverageDetails
Market Size Value inUS$ 6,406.3 Million in 2017
Market Size Value byUS$ 13,850.2 Million by 2025
Growth rateCAGR of 10.5% from 2018-2025
Forecast Period2018-2025
Base Year2018
No. of Pages146
No. of Tables61
No. of Charts & Figures47
Historical data availableYes
Segments coveredProduct By Procedure ; By End User and Geography
Regional scopeNorth America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country scopeUS, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

Acquisitions and expansions were observed as the most adopted strategy in global structural heart industry. Few of the acquisitions and expansions made by the players in the market are listed below:

2018: In July, 2018, Boston Scientific Corporation announced signing of agreement to acquire Claret Medical, Inc., a privately-held company that has developed and commercialized the Sentinel Cerebral Embolic Protection System.

2017: In November, 2017, Edwards Lifesciences Corporation, announced it expansion, the expansion was done in the Costa Rica a new manufacturing plant was started.



By Product

  • Occluders
  • Annuloplasty Rings
  • Heart Valve Balloons
  • Others

By Procedure

  • Surgical Aortic Valve Replacement
  • Transcatheter Aortic Valve Replacement
  • Mitral Repair
  • Left Atrial Appendage Closure

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Centers

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • UAE
  • South America (SAM)
    • Brazil

Company Profiles

  • Abbott
  • Medtronic
  • Boston Scientific Corporation
  • CryoLife, Inc
  • Edward Lifesciences Corporation
  • LivaNova Plc
  • Lepu Medical
  • Braile Biomedica
  • Labcor Laboratories Ltda
  • Aran Biomedical Teoranta

The List of Companies

  1. Abbott
  2. Medtronic
  3. Boston Scientific Corporation
  4. CryoLife, Inc
  5. Edward Lifesciences Corporation
  6. LivaNova Plc
  7. Lepu Medical
  8. Braile Biomedica
  9. Labcor Laboratories Ltda
  10. Aran Biomedical Teoranta
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the structural heart market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global structural heart market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market


Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000 $2700
  • $4550 $3000
  • $6550 $4000
  • $8550 $5000

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount